• Research Findings and Conclusion
Peptide-Based Gastrointestinal Disorders Therapeutics Market Regional Analysis
North America peptide-based gastrointestinal disorders therapeutics market is expected to exhibit
good growth over the forecast period, owing to presence of major players and adoption of
strategies such as mergers and collaborations by them for novel peptide-based therapeutics. For
instance, in February 2018, Cipher Pharmaceuticals Inc. acquired exclusive Canadian rights of
the U.S. Food and Drug Administration approved drug Trulance (plecanatide) from Synergy
Pharmaceuticals Inc. After the acquisition, Cipher Pharmaceuticals Inc. will develop, market,
distribute, and sell Trulance (plecanatide) in the Canadian Market.
Browse Report For More Information @ https://www.coherentmarketinsights.com/ongoing-
insight/peptide-based-gastrointestinal-disorders-therapeutics-market-2028
Asia Pacific peptide-based gastrointestinal disorders therapeutics market is expected to exhibit
significant growth over the forecast period, owing to increasing investments made by players in
the region to receive approval of novel peptide-based therapeutics. For instance, in 2014,
Ironwood Pharmaceuticals, Inc. received US$ 15 million from Astellas Pharma Inc., a Japan-
based pharmaceutical company, for initiating Phase III clinical trial of Linzess (linaclotide) in
Japan, and receive its approval from Japanese Ministry of Health, Labor, and Welfare in 2016.
Ironwood Pharmaceuticals, Inc. and Astellas Pharma Inc. were under strategic partnership since
2009 for developing and commercializing linaclotide in Japan.
Peptide-Based Gastrointestinal Disorders Therapeutics Market Key Players
Key players operating in the global peptide-based gastrointestinal disorders therapeutics market
include Ironwood Pharmaceuticals, Inc., NPS Pharmaceuticals, Inc., Synergy Pharmaceuticals
Inc., Astellas Pharma Inc., Allergan plc., and Cipher Pharmaceuticals Inc.
About Coherent Market Insights
Coherent Market Insights is a prominent market research and consulting firm offering action-
ready syndicated research reports, custom market analysis, consulting services, and competitive
analysis through various recommendations related to emerging market trends, technologies, and
potential absolute dollar opportunity.